LOCAL ANESTHETIC AGENTS - PowerPoint PPT Presentation

1 / 45
About This Presentation
Title:

LOCAL ANESTHETIC AGENTS

Description:

LOCAL ANESTHETIC AGENTS History of local anesthesia 1500 s Accounts referring to Peruvian Indians chewing on leaves of the coco plant are found 1884 Cark Koller ... – PowerPoint PPT presentation

Number of Views:2174
Avg rating:3.0/5.0
Slides: 46
Provided by: Anesthsi1
Category:

less

Transcript and Presenter's Notes

Title: LOCAL ANESTHETIC AGENTS


1
LOCAL ANESTHETIC AGENTS
2
(No Transcript)
3
History of local anesthesia
  • 1500s Accounts referring to Peruvian Indians
    chewing on leaves of the coco plant are found
  • 1884 Cark Koller demonstrated the usefulness of
    the extract from these leavescocaineas a
    topical anesthetic for the eyes, and earned
    distinction as the father of local anesthesia
  • 1884 Willium Halsted used cocaine in the first
    nerve block Inferior alveolar nerve block. The
    use of cocaine for anesthesia produced several
    unwanted side effects including cardiac problem
    and addiction
  • 1885 James Corning demonstrated the use of a
    tourniquet to slow absorption of cocaine

4
History of local anesthesia
  • 1901 Heinrich Braun demonstrated the use of
    epinephrine to retard local anesthetic absorption
    from the site of injection
  • 1904 Alfred Einhorn introduced procaine .
    Epinephrine was needed to constrict the vessels
    in the area of administration to lengthen the
    duration of anesthesia. It was common to see a
    150,000 concentration for many years
  • 1943 Nils Lofgren introduced lidocaine
  • 1947 Novocol company made the dental aspirating
    syringe available
  • 1959 Disposable sterile needles made available by
    Cook- Waite, Roehr Company

5
(No Transcript)
6
Physiology of nerve conduction
7
(No Transcript)
8
Sodium-potassium Pump
9
Channel Entry
10
(No Transcript)
11
(No Transcript)
12
(No Transcript)
13
Local anestheticsamides vs. esters
14
Classification of local anesthetics
Amides Ester
Bupivacaine Benzocaine
Lidocaine Cocaine
Mepivacaine Procaine
Prilocaine
15
(No Transcript)
16
Absorption
  • Site of injection
  • The dose of local anesthetic
  • Physicochemical properties of local anesthetic
  • The addition of epinephrine

17
Distribution
  • Site of injection

Systemic absorption
heart
brain
Skeletal muscle
18
Biotransformation and Elimination
  • Aminoester Aminoamide
  • Plasma esterase Hepatic enzyme
  • Renal excretion

19
?????????????????????????????
  • ???? ???????????????????????????????
  • ?????? ????? half life ????????????
  • cardiac output ????? cardiac output ???
    ???????????????????

20
  • Potency lipid solubility
  • Onset pKa, concentration of local anesthetic

21
What is pKa?
  • pKa pH log RNH
  • RN
  • (modified Henderson- Hasselbalch equation)
  • pKa is the dissociation constant, represents
    the
  • pH at which the concentration of the
  • ionized base(RNH) and the non-ionized
  • base (RN) are equal.

22
  • RNH RN H

Outside membrane
Inside membrane
  • RNH RN H

23
Anesthetic pKa RN at pH 7.4 Onset min
Mepivacaine 7.6 40 2-4
Etidocaine 7.7 33 2-4
Articaine 7.8 29 2-4
Lidocaine 7.9 25 2-4
Prilocaine 7.9 25 2-4
Bupivacaine 8.1 18 5-8
Procaine 9.1 2 14-18
24
Example at physiologic pH (7.4)
Lidocaine Procaine
pKa 7.9 31 ionized to non-ionized 8.9 321, ionized to non-ionized
onset 2 to 3 minutes 6 to 12 minutes
  • if lidocaine (pKa 7.9) is administered into an
    area of infection (pH 4.9) resulting 1,0001
    ionized to non-ionized indicates a poorer
    penetration into the nerve tissue and therefore a
    less effective nerve block

25
Quinn and Malamed (1990) and Haegerstam(1990)
suggested of administer L.A.
  • AWAY from the area of inflammation (nerve block)
    especially in the area of EXTENSIVE CELLULITIS
  • Malamed. Handbook of LOCAL ANESTHESIA 1990.
  • Haegerstam, Introduction to Dental Local
    anesthesia 1990.

26
  • Duration of action
  • Differential sensory/ motor blockade
  • Adverse reaction

27
Clinical use of local anesthesia
  • Topical anesthesia
  • Infiltration
  • Peripheral nerve block
  • Epidural block
  • Spinal block
  • Intravenous regional anesthesia

28
Toxicity
29
Clinical sign and symptom LA toxicity
30
CNS toxicity
  • Potency
  • The rate of intravenus administration
  • Acid base status and PaCO2

31
Cardiovascular toxicity
32
CC/CNS Ratio
  • i.e. the ratio of the LA dosage required for
    irreversible cardiovascular collapse and the
    dosage that produces CNS toxicity (convulsions)
  • the higher the CC/CNS ratio the better the safety
    margin

33
(No Transcript)
34
(No Transcript)
35
Prevention
  • Aspiration before injection
  • Inject slowly
  • Use smallest quantity of solution and lowest
    concentration of vasoconstrictor
  • Observe the patient after injection
  • Choose another anesthetic if the patient has
    tendency for allergic reaction

36
The signs and symptoms of allergic reaction
include
  • generalized body rash or skin redness
  • itching, urticaria (hives)
  • bronchospasm (difficulty breathing)
  • swelling of the throat
  • asthma
  • abdominal cramping
  • irregular heartbeat
  • hypotension (low blood pressure)
  • swelling of the face and lips (angioneurotic
    edema)

37
Adverse reactions of commonly usedlocal
anesthetics
  • Methemoglobinemia
  • associated with prilocaine, articaine,
    benzocaine
  • Local tissue toxicity

38
epinephrine
39
  • Receptor Response
  • Alpha stimulation Vasoconstriction
  • Peripheral resistance
  • Beta 1 stimulation Heart rate
  • Force of cardiac contraction
  • Cardiac output
  • Beta 2 stimulation Vasodilatation
  • Bronchodilation

  • Coronary blood flow

40
Adverse reactions of vasopressor drugs
  • Signs
  • Elevated BP, HR
  • Symptoms
  • Fear
  • Anxiety
  • Restlessness
  • Throbbing headache
  • Tremor
  • Dizziness
  • Pallor
  • Respiratory difficulty
  • Palpitations

41
Contraindication for Epinephrine
  • Blood pressure over 200 torr systolic or 115 torr
    diastolic
  • Uncontrolled hypertension
  • Severe cardiovascular disease including less than
    6 months after a myocardial infarction or
    cerebrovascular accident
  • Daily episodes of angina pectoris or unstable
    angina
  • Cardiac dysrhythmias despite appropriate therapy
  • Medicated with beta blocker,monoamine oxidase
    inhibitor , or tricyclic antidepressant or
    general anesthesia with a halogenated anesthetic
    like halothane

42
New York Heart Association
  • ?????????????? epinephrine ?????? 3 ug. / kg.
    Body weight ????????????? 0.2 mg. (200 µg)
  • ?????????????????????????? ??????????????????
    ???????? ?????? Epinephrine ?????? 40 ug
    ????????? ?????????? 54 µg ?????????????????????

43
?????????????????? Epinephrine
  • Epinephrine ???? 1 200,000
  • 1 gm / 200,000 ml
  • 1,000 mg / 200,000 ml
  • 1 mg / 200 ml
  • 0.005 mg / 1 ml

44
??????????????? 2 ?? ???? 12 ???????? ????????????
??????????? ??????????? ???????????????? ?????????
?????????????????
45
?????????????? 25 ?? ??????? 60
???????? ???????????????? ????????????????????????
????????????????????
Write a Comment
User Comments (0)
About PowerShow.com